Why Alzheimer’s research is failing to hit treatment targets

Since Alois Alzheimer first described a “peculiar severe disease” in 1901, research into dementia has grown at an astonishing rate. As the prevalence of Alzheimer’s disease increases, the need for a treatment becomes more pressing and scientists trying to understand the disease are more accountable than ever. While there has been significant investment and encouraging progress, therapies are still limited. And as the pressure on those affected by and working in the field of Alzheimer’s intensifi...
More

Research into cure for dementia

Frank Cadman Styers III Frank Cadman Styers III was awarded the Local Government Federal Credit Union Scholarship Award this summer. By Allison Barrett Carter StarNews Correspondent Frank Cadman Styers III, known to friends and family as “Cadman,” was awarded the LGFCU Scholarship Award this summer. The Local Government Federal Credit Union Scholarship Award recognizes a student’s high achievement in extracurricular activities as well as academics. Students must have maintained a grade po...
More

Alleviate Alzheimer’s symptoms

Researchers have discovered a protein that may alleviate some of the most common symptoms of Alzheimer’s disease. When injected into the brains of mice, neurogulin-1 has been able to promote the metabolism of plaques — abnormal clusters of protein fragments — that build up in the brain and restrain function, according to new research published in Scientific Reports. The mice, when neurogulin-1 was in their hippocampus (the part of the brain that is responsible for learning and memory) showed ...
More

Alzheimer’s Vaccine – possible cure on the Horizon?

A team of researchers says it has created what could become the world’s first viable Alzheimer's vaccine against Alzheimer’s disease, although others in the field remain skeptical, this can be a possible cure for Alzheimer's. An article published online earlier this month in Nature’s Scientific Reports describes the study, which was conducted on mice, as “promising.” The vaccine simultaneously targets beta-amyloid and tau, the two proteins that have been implicated in the brain plaques and ta...
More

Researchers Alzheimer’s vaccine

Researchers discover molecule for potential Alzheimer's vaccine A team of researchers have discovered a new molecule that they say may be a major step towards the creation of an Alzheimer’s vaccine. The molecule, known as monophosphoryl lipid A (MPL), has shown evidence of stimulating the brain’s natural immune defense against the symptoms of Alzheimer’s, according to a team of researchers from Laval University in Quebec and pharmaceutical firm GlaxoSmithKline (GSK). Alzheimer’s is often ...
More

Alzheimer’s gene e4 may shrink brain regions in childhood

Study found that children with the Alzheimer's gene e4 had differences in their brain development compared to children with Alzheimer's e2 and e3 forms of the gene. Washington: The Alzheimer's gene e4 associated with Alzheimer's disease may shrink brain regions and reduce thinking skills as early as childhood, a finding that may help researchers develop ways to prevent the disease from occurring, according to a new study. Prior studies showed that people with the epsilon (e) 4 mvariant o...
More